Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus

Mitchell Maiman, Rachel G. Fruchter, Alexander Sedlis, Joseph Feldman, Patrick Chen, Robert D. Burk, Howard Minkoff

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Objectives. The objective was to evaluate the sensitivity and specificity of cervical cytology in women infected with the human immunodeficiency virus (HIV), risk factors for abnormal cytology in HIV- infected and uninfected women, and risk factors for histologic diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-infected women. Methods. Methods included a cross-sectional analysis of cervical cytology, colposcopic impression, and histology in 248 HIV-infected women and multivariate analyses of risk factors for abnormal cytology in 253 HIV-infected and 220 uninfected women and risk factors for CIN in 186 HIV-infected women. Results. The sensitivity and specificity of cytology for all CIN grades were 0.60 and 0.80 and, for high-grade CIN, 0.83 and 0.74. The prevalence of abnormal cytology was 32.9% in HIV-infected and 7.6% in HIV-negative women. Independent risk factors for abnormal cytology were immunodeficiency [odds ratio (OR) 8-17, P < 0.001] and human papillomavirus (HPV) infection (OR = 5, P < 0.001). The prevalence of CIN on histology was 32% in HIV-infected women, and the only independent risk factor for CIN was oncogenic HPV type (OR = 5, P = 0.005). Conclusion. Given the high prevalence of abnormal cytology and CIN in HIV- infected women, cytologic screening has significant limitations. Both immunodeficiency and type of HPV infection are important risk factors.

Original languageEnglish (US)
Pages (from-to)233-239
Number of pages7
JournalGynecologic Oncology
Volume68
Issue number3
DOIs
StatePublished - Mar 1998

Fingerprint

Cervical Intraepithelial Neoplasia
HIV
Cell Biology
Papillomavirus Infections
Odds Ratio
Histology
Sensitivity and Specificity
Multivariate Analysis
Cross-Sectional Studies

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. / Maiman, Mitchell; Fruchter, Rachel G.; Sedlis, Alexander; Feldman, Joseph; Chen, Patrick; Burk, Robert D.; Minkoff, Howard.

In: Gynecologic Oncology, Vol. 68, No. 3, 03.1998, p. 233-239.

Research output: Contribution to journalArticle

Maiman, Mitchell ; Fruchter, Rachel G. ; Sedlis, Alexander ; Feldman, Joseph ; Chen, Patrick ; Burk, Robert D. ; Minkoff, Howard. / Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. In: Gynecologic Oncology. 1998 ; Vol. 68, No. 3. pp. 233-239.
@article{2dbc591dfdae4604a735e8c217ab3ada,
title = "Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus",
abstract = "Objectives. The objective was to evaluate the sensitivity and specificity of cervical cytology in women infected with the human immunodeficiency virus (HIV), risk factors for abnormal cytology in HIV- infected and uninfected women, and risk factors for histologic diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-infected women. Methods. Methods included a cross-sectional analysis of cervical cytology, colposcopic impression, and histology in 248 HIV-infected women and multivariate analyses of risk factors for abnormal cytology in 253 HIV-infected and 220 uninfected women and risk factors for CIN in 186 HIV-infected women. Results. The sensitivity and specificity of cytology for all CIN grades were 0.60 and 0.80 and, for high-grade CIN, 0.83 and 0.74. The prevalence of abnormal cytology was 32.9{\%} in HIV-infected and 7.6{\%} in HIV-negative women. Independent risk factors for abnormal cytology were immunodeficiency [odds ratio (OR) 8-17, P < 0.001] and human papillomavirus (HPV) infection (OR = 5, P < 0.001). The prevalence of CIN on histology was 32{\%} in HIV-infected women, and the only independent risk factor for CIN was oncogenic HPV type (OR = 5, P = 0.005). Conclusion. Given the high prevalence of abnormal cytology and CIN in HIV- infected women, cytologic screening has significant limitations. Both immunodeficiency and type of HPV infection are important risk factors.",
author = "Mitchell Maiman and Fruchter, {Rachel G.} and Alexander Sedlis and Joseph Feldman and Patrick Chen and Burk, {Robert D.} and Howard Minkoff",
year = "1998",
month = "3",
doi = "10.1006/gyno.1998.4938",
language = "English (US)",
volume = "68",
pages = "233--239",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus

AU - Maiman, Mitchell

AU - Fruchter, Rachel G.

AU - Sedlis, Alexander

AU - Feldman, Joseph

AU - Chen, Patrick

AU - Burk, Robert D.

AU - Minkoff, Howard

PY - 1998/3

Y1 - 1998/3

N2 - Objectives. The objective was to evaluate the sensitivity and specificity of cervical cytology in women infected with the human immunodeficiency virus (HIV), risk factors for abnormal cytology in HIV- infected and uninfected women, and risk factors for histologic diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-infected women. Methods. Methods included a cross-sectional analysis of cervical cytology, colposcopic impression, and histology in 248 HIV-infected women and multivariate analyses of risk factors for abnormal cytology in 253 HIV-infected and 220 uninfected women and risk factors for CIN in 186 HIV-infected women. Results. The sensitivity and specificity of cytology for all CIN grades were 0.60 and 0.80 and, for high-grade CIN, 0.83 and 0.74. The prevalence of abnormal cytology was 32.9% in HIV-infected and 7.6% in HIV-negative women. Independent risk factors for abnormal cytology were immunodeficiency [odds ratio (OR) 8-17, P < 0.001] and human papillomavirus (HPV) infection (OR = 5, P < 0.001). The prevalence of CIN on histology was 32% in HIV-infected women, and the only independent risk factor for CIN was oncogenic HPV type (OR = 5, P = 0.005). Conclusion. Given the high prevalence of abnormal cytology and CIN in HIV- infected women, cytologic screening has significant limitations. Both immunodeficiency and type of HPV infection are important risk factors.

AB - Objectives. The objective was to evaluate the sensitivity and specificity of cervical cytology in women infected with the human immunodeficiency virus (HIV), risk factors for abnormal cytology in HIV- infected and uninfected women, and risk factors for histologic diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-infected women. Methods. Methods included a cross-sectional analysis of cervical cytology, colposcopic impression, and histology in 248 HIV-infected women and multivariate analyses of risk factors for abnormal cytology in 253 HIV-infected and 220 uninfected women and risk factors for CIN in 186 HIV-infected women. Results. The sensitivity and specificity of cytology for all CIN grades were 0.60 and 0.80 and, for high-grade CIN, 0.83 and 0.74. The prevalence of abnormal cytology was 32.9% in HIV-infected and 7.6% in HIV-negative women. Independent risk factors for abnormal cytology were immunodeficiency [odds ratio (OR) 8-17, P < 0.001] and human papillomavirus (HPV) infection (OR = 5, P < 0.001). The prevalence of CIN on histology was 32% in HIV-infected women, and the only independent risk factor for CIN was oncogenic HPV type (OR = 5, P = 0.005). Conclusion. Given the high prevalence of abnormal cytology and CIN in HIV- infected women, cytologic screening has significant limitations. Both immunodeficiency and type of HPV infection are important risk factors.

UR - http://www.scopus.com/inward/record.url?scp=0032031013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032031013&partnerID=8YFLogxK

U2 - 10.1006/gyno.1998.4938

DO - 10.1006/gyno.1998.4938

M3 - Article

C2 - 9570972

AN - SCOPUS:0032031013

VL - 68

SP - 233

EP - 239

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -